Management Board meeting: 21 March 2019

• Date:
  Ceturtdiena, 21 Marts 2019, Visu dienu
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.

Documents

Minutes of the 103rd meeting of the Management Board: 21 March 2019

Adopted Reference Number: EMA/MB/188256/2019

Agenda for the 103rd meeting of the Management Board

Adopted Reference Number: EMA/MB/916015/2019

Minor use or minor species (MUMS)/limited market scheme for veterinary medicinal products - 9th annual report (2018)

Reference Number: EMA/713390/2018

Decision on amending budget No 1-2019

Reference Number: EMA/MB/171445/20199

Outcome of written procedures finalised during the period from 24 November 2018 to 22 February 2019

Reference Number: EMA/MB/112294/2019

Rules for reimbursement of expenses for delegates attending meetings with effect from 17 March 2023

Adopted Reference Number: EMA/MB/279597/2018 Rev. 5

Rules for the implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures - Revised implementing rules to the Fee Regulation as of 1 April 2019

Reference Number: EMA/MB/909612/2019

Summary of transfers of appropriations in budget 2018 - Management Board meeting of 21 March 2019

Reference Number: EMA/MB/129665/2019

2018 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission - Reporting period: 1 January to 31 December 2018